丹酚酸B磷脂复合物自乳化药物传递系统的制备及质量评价
Optimization and Characterization of SalB-PC Loaded Self-emulsifying Drug Delivery System
-
摘要: 目的 制备丹酚酸B磷脂复合物(SalB-PC)自乳化药物传递系统(SEDDS),并对其进行质量评价。 方法 利用单因素筛选和伪三元相图法,根据乳化效率、乳化后样品的性状及其粒径等指标,筛选出最优处方,并对自乳化制剂的形态学、粒径和电位,以及在人工肠液中的释放特性等质量指标进行考察。 结果 最优处方:SalB-PC:Lauroglycol FCC:Cremophor EL:Transcutol P的质量比为9:45:40:15。SalB-PC自乳化制剂为黄色澄清液体,经过100倍稀释形成的乳剂粒径为(187.2±7.1)nm,多分散指数(PDI)为0.267±0.008,zeta电位为(-35.6±2.7)mV,在人工肠液中的释放速率比SalB溶液和SalB-PC溶液缓慢。 结论 水溶性药物丹酚酸B可以制备成自乳化给药系统,该剂型能减缓SalB在人工肠液中的释放速率。Abstract: Objective To prepare self-emulsifying delivery system (SEDDS) of Salvianolic acid B phospholipid complex (SalB-PC) and evaluate its quality. Methods The best formulation was optimized using single-factor and pseudo-ternary phase diagrams, according to the emulsifying efficiency, the characteristics and partical size of the emulsion and other indicators. The morphology, particle size, zeta-potential and the release in artificial intestinal fluid of self-emulsifying formulation were evaluated. Results The weight ratio of SalB-PC:Lauroglycol FCC:Cremophor EL:Transcutol P in the best formulation was 9:45:40:15. SalB-PC loaded self-emulsifying formulation is yellow and transparent solution, with partical size about (187.2±7.1) nm, polydispersity index (PDI) about 0.267±0.008 and zeta-potential about (-35.6±2.7) mV after diluted about 100-fold. The self-emulsifying formulation released slower than the solution with only SalB or SalB-PC. Conclusion Water-soluble drug Salvianolic acid B can be prepared to SEDDS, and this formulation can slow down the release of SalB in artificial intestinal fluid.
© 2013 《koko体育app
学报(医学版)》编辑部 版权所有
开放获取♒ 本文遵循知识共享署名—非商业性使用4.0国际许可协议(CC BY-NC 4.0),允许第三方对本刊发表的论文自由共享(即在任何媒介以任何形式复制、发行原文)、演绎(即修改、转换或以原文为基础进行创作),必须给出适当的署名,提供指向本文许可协议的链接,同时标明是否对原文作了修改;不得将本文用于商业目的。CC BY-NC 4.0许可协议详情请访问